Does risk exist in severe burned patients applied with recombinant growth hormone? / 中华临床营养杂志
Chinese Journal of Clinical Nutrition
;
(6): 4-6, 2009.
Article
in Chinese
| WPRIM
| ID: wpr-395145
ABSTRACT
Effectiveness of recombinant human growth hormone ( rhGH) in treating critically ill or severe burned patients have been demonstrated. Although adverse effects of rhGH have also been identified, they are controllable. The dosage and timing of rhGH must be well designed, and hyperglycemia be controlled. Application of rhGH in critically ill patients should be deliberately considered.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Etiology study
Language:
Chinese
Journal:
Chinese Journal of Clinical Nutrition
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS